ArticleDiscover oncology2026
Exploring the potential mechanisms of hydroquinone on bladder cancer using network toxicology, Mendelian randomization analysis, molecular docking, and molecular dynamics simulations.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundEnvironmental pollutants, especially hydroquinone (HQ), a phenolic compound, pose major global health risks and may be linked to bladder cancer (BC). This study examines HQ’s role in BC development.
methodsMendelian randomization (MR) analysis was employed to explore the potential relationship between HQ and BC. Toxicological targets of HQ were identified using ChEMBL and SwissTargetPrediction databases, while BC-related genes were extracted from the GEO database. Core targets were identified through machine learning algorithms, including Lasso, SVM-RFE, and RF, and validated via molecular docking and dynamics simulations.
resultsA significant causal relationship between HQ and BC was found. Eleven candidate targets were identified through intersection analysis of HQ-related toxicological targets and BC-related differential genes. Six core targets—ALDH1A1, PMP22, TDP1, HBB, LMNA, and CA2—were selected. Single-cell sequencing analysis revealed their primary expression in fibroblasts and epithelial cells. Molecular docking and dynamics simulations confirmed strong binding between HQ and these core targets.
conclusionThis study combines MR analysis and network toxicology to uncover the causal link between HQ and BC, identifying key molecular targets. These findings provide insights into the mechanisms of HQ in BC and offer potential biomarkers and therapeutic targets for future treatments and preventive strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.